It’s a pretty remarkable ROI for Pandion investors after the biotech went public back in July for ... drug candidates and one clinical drug candidate in development for autoimmune diseases. ... ALIGN="center">
Pretty ones, 021 @iMGSRC.RU
3925e8d270
Comments